Cognition and Ultrasound
1 other identifier
interventional
100
1 country
1
Brief Summary
Our primary goal is to investigate the role of Low-Intensity Focused Ultrasound (LIFU) neuromodulation on deep brain targets, and its potential to improve cognition
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2024
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2024
CompletedFirst Submitted
Initial submission to the registry
October 22, 2025
CompletedFirst Posted
Study publicly available on registry
October 24, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 1, 2028
October 24, 2025
October 1, 2025
4.1 years
October 22, 2025
October 22, 2025
Conditions
Outcome Measures
Primary Outcomes (3)
Deep Brain Targets Reached
MRI-based readouts testing whether LIFU neuromodulation can successfully engage targets in deep brain
Hour 1
Multi-Source Interference Test (MSIT) Performance
Behavioral readouts of successful LIFU neuromodulation of our target regions
Hour 1
28/Posit Science Performance
Behavioral readouts of successful LIFU neuromodulation of our target regions
Hour 1
Study Arms (1)
Low-Intensity Focused Ultrasound
EXPERIMENTALInterventions
We will use an established, currently-marketed device to deliver LIFU neuromodulation.
Eligibility Criteria
You may qualify if:
- years of age or older
- Speak English (as assessed by their ability to read/answer survey questions)
- May be required to score in the appropriate range on self-report measures
You may not qualify if:
- They have a neurological disorder which may impact their fMRI scan or cause their reaction to LIFU to differ from that of healthy adults.
- They take any psychoactive medication.
- They are unable to undergo fMRI scanning due to a contraindication such as claustrophobia, unremovable piercings, pregnancy, the presence of medical devices such as pacemakers, or a movement or sleep disorder.
- Are pregnant, or may have reason to believe that they are pregnant.
- They have a diagnosis of a psychiatric condition other than depression or anxiety
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Minnesota
Minneapolis, Minnesota, 55455, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Michael Bronstein
University of Minnesota
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 22, 2025
First Posted
October 24, 2025
Study Start
June 1, 2024
Primary Completion (Estimated)
July 1, 2028
Study Completion (Estimated)
July 1, 2028
Last Updated
October 24, 2025
Record last verified: 2025-10
Data Sharing
- IPD Sharing
- Will not share